LBO — POMERENE HOSPITAL
IRR: 17.7% | MOIC: 2.26x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.7%
IRR
2.26x
MOIC
$37.6M
Entry EV
$59.1M
Exit EV
$19.3M
Equity Invested
Sources & Uses
S&UTotal · $37.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $14.6M | 38.8% | |
| Sub Debt | $3.7M | 9.7% | |
| Equity | $19.3M | 51.5% | |
| Enterprise Value | $36.5M | 97.1% | |
| Transaction Fees | $1.1M | 2.9% | |
| Total Uses | $37.6M | 100.0% |
Interpretation
INTAt 2.26x MOIC and 17.7% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $5.6M |
| Exit Ev | $59.1M |
| Net Debt At Exit | $15.4M |
| Equity At Exit | $43.7M |
| Equity Invested | $19.3M |
| Total Value Created | $24.3M |
| Value From Growth | $20.7M |
| Value From Multiple | $1.8M |
| Value From Deleveraging | $2.9M |